Gilva Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6.09M

  • Investors
  • 5

Gilva Therapeutics General Information

Description

Developer of biopharmaceutical drugs intended to advance the treatment of chronic and complex diseases through novel small-molecule drug discovery and development. The company offers a proprietary drug design platform, medicinal chemistry expertise, and a diverse chemical compound library, enabling pharmaceutical researchers and patients with kidney, fibrotic, neurodegenerative, and inflammatory diseases to access drug candidates with enhanced selectivity, bioavailability, and therapeutic potential.

Contact Information

Website
gilvatherap.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 909, Elite Research Building, National Taiwan University
  • Number 18, Siyuan Street, Zhongzheng District
  • Taipei
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Room 909, Elite Research Building, National Taiwan University
  • Number 18, Siyuan Street, Zhongzheng District
  • Taipei
  • Taiwan
+886 02

Gilva Therapeutics Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gilva Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 01-Mar-2025 $6.09M Completed Generating Revenue
7. Early Stage VC 01-Feb-2025 Completed Generating Revenue
6. Early Stage VC 01-Jan-2025 Completed Generating Revenue
5. Early Stage VC 05-Mar-2024 Completed Generating Revenue
4. Early Stage VC 01-Mar-2024 Completed Generating Revenue
3. Early Stage VC 01-Mar-2024 Completed Generating Revenue
2. Seed Round 01-Nov-2023 $1.38M $1.38M Completed Startup
1. Seed Round Completed Startup
To view Gilva Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gilva Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Gilva Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026161747-A1 Metalloenzyme inhibitors and uses thereof Pending 23-Jan-2025

Gilva Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Industrial Technology Transfer Corporate Venture Capital Minority
Forward Asset Management Venture Capital Minority
Fubon Financial Holding Venture Capital Venture Capital Minority
Alar Pharmaceuticals Corporation Minority
National Development Fund of Taiwan Sovereign Wealth Fund Minority
To view Gilva Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Gilva Therapeutics FAQs

  • When was Gilva Therapeutics founded?

    Gilva Therapeutics was founded in 2023.

  • Where is Gilva Therapeutics headquartered?

    Gilva Therapeutics is headquartered in Taipei, Taiwan.

  • What industry is Gilva Therapeutics in?

    Gilva Therapeutics’s primary industry is Drug Discovery.

  • Is Gilva Therapeutics a private or public company?

    Gilva Therapeutics is a Private company.

  • What is Gilva Therapeutics’s current revenue?

    The current revenue for Gilva Therapeutics is .

  • How much funding has Gilva Therapeutics raised over time?

    Gilva Therapeutics has raised $30.4M.

  • Who are Gilva Therapeutics’s investors?

    Innovation Industrial Technology Transfer, Forward Asset Management, Fubon Financial Holding Venture Capital, Alar Pharmaceuticals, and National Development Fund of Taiwan have invested in Gilva Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process